Clinical Trial Recruitment in Autoimmune Disorders-Average Patient Recruitment Per Trial has Continued to Decline Over the Past Decade - GBI Research Reports

Clinical Trial Recruitment in Autoimmune Disorders-Average Patient Recruitment Per Trial has Continued to Decline Over the Past Decade

Clinical Trial Recruitment in Autoimmune Disorders-Average Patient Recruitment Per Trial has Continued to Decline Over the Past Decade - GBI Research Reports
Clinical Trial Recruitment in Autoimmune Disorders-Average Patient Recruitment Per Trial has Continued to Decline Over the Past Decade
Published Sep 01, 2011
95 pages — Published Sep 01, 2011
Price US$ 3,500.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

GBI Research, the leading business intelligence provider, has released its latest research Clinical Trial Recruitment in Autoimmune Disorders-Average Patient Recruitment per Trial has Continued to Decline Over the Past Decade which provides an insight into clinical trial and patient recruitment in Autoimmune Disorders. The report examines different aspects concerning clinical trial and patient recruitment. The report analyzes the number of clinical trials and the number of patients recruited for five major indications such as Multiple Sclerosis, Rheumatoid Arthritis, Crohn's Disease, Ulcerative Colitis and Psoriasis. It provides information about the total number of clinical trials conducted, by stage of development, geography, major sponsors and trails conducted per year. Analysis on the total number of patients recruited and the average number of patients recruited per each trial is also provided. The report analyzes the total number of patients recruited by stage of development, geography, major sponsors and trails conducted per year from 2000 to 2009. The average number of patients recruited by stage of development per year is also covered. For Brazil, China and India, an estimate of the prevalence population has also been provided for the years 2010 to 2017 across the five major Autoimmune Disorders.

Autoimmune Disorders represent a collective group of disorders which primarily arise due to an overactive immune response of the body against substances and tissues normally present within the body. Major clinical trial recruitment is conducted for Rheumatoid Arthritis. The numbers of clinical trials and patients recruited for this disease are 230 and 19,087 respectively. The average number of patients recruited per trial is highest for Rheumatoid Arthritis when compared to that of other indications.

Scope

- The report covers clinical trials, patient recruitment, average patient recruitment and prevalence population estimation for five major autoimmune disorders. The prevalence estimates is done for countries such as Brazil, India and China.
- The report covers different types of study designs and challenges faced in clinical trial recruitment as a whole.
- Status of Clinical Trials: It covers clinical trials for five major indications by stage of development, by sponsor, by geography and clinical trials conducted per year.
- Status of Patient Recruitment: It includes patient recruitment for five major indications by stage of development, by sponsor, by geography and clinical trials conducted per year. The report emphasizes on the average number of patients recruited per trial by stage of development and by year.
- Prevalence Population Estimation: The estimation for the years 2010 to 2017 gives an idea about the prevalence of the five major indications in the future.

Reasons to buy

The report will assist business development and marketing executives to strategize their product launches, by allowing them to -
- Develop a better study design for better patient recruitment.
- Plan an effective clinical trial recruitment management by understanding the trend of clinical trials and patient recruitment conducted for five major Autoimmune Disorders for the period 2000 to 2009
- Understand the clinical trial trend across the globe for major indications in Autoimmune Disorders which covers an in-depth analysis on clinical trials by Phase, by sponsor, by geography and by year.
- Understand the trend of patient recruitment across the globe for major indications in Autoimmune Disorders which covers an in-depth analysis on patient recruitment by Phase, by sponsor, by geography and by year.
- Know the top companies that conducted highest clinical trial recruitment by indication and Develop key strategic initiativ

  
Source:
Document ID
GBIHC118MR
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents39
  List of Tables63
  List of Figures93
Clinical Trial Recruitment in Autoimmune Disorders- Introduction122
  GBI Research Report Guidance122
Clinical Trial and Patient Recruitment - Overview143
  Effect of Clinical Trial Study Design on Patient Recruitment141
    Types of Study Designs141
  Current Challenges in Clinical Trial Recruitment and Enrollment151
    Challenges in Clinical Trials Due to Stringent Inclusive and Exclusive Criteria151
      Lack of Awareness of Appropriate Clinical Trials151
      Knowledge about Regulations151
      Required Infrastructure151
      Belief in Doctors and the Patients that Standard Therapy is Best161
    Challenges in Clinical Research- Volunteer Perspective161
      Lack of Access to Trials161
      Fear, Distrust or Suspicions of Research161
      Practical or Personal Obstacles161
      Insurance and Financial Problems161
      Long-standing Fear, Apprehension and Disbelief161
Clinical Trial Recruitment in Autoimmune Disorders - Overview174
  Clinical Trial Share by Therapeutic Area171
  Clinical Trials for the Five Major Indications in Autoimmune Disorders181
  Patient Recruitment for the Five Major Indications in Autoimmune Disorders191
  Major Indications in Autoimmune Disorders201
Clinical Trials and Patient Recruitment for Multiple Sclerosis2115
  Multiple Sclerosis- Overview212
  Clinical Trials for Multiple Sclerosis231
    Number of Clinical Trials by Stage of Development231
    Number of Clinical Trials by Sponsor241
    Number of Clinical Trials by Geography251
    Number of Clinical Trials per Year261
  Patient Recruitment for Multiple Sclerosis271
    Number of Patients Recruited by Stage of Development271
    Number of Patients Recruited by Sponsor281
    Number of Patients Recruited by Geography291
    Number of Patients Recruited per Year301
  Average Number of Patients Recruited per Trial311
    Average Number of Patients Recruited per Trial by Stage of Development311
    Average Number of Patients Recruited per Trial per Year321
  Prevalence Population for Multiple Sclerosis in Brazil, China and India331
    Prevalence Population for Multiple Sclerosis in Brazil (2010-2017)331
    Prevalence Population for Multiple Sclerosis in China (2010-2017)341
    Prevalence Population for Multiple Sclerosis India (2010-2017)351
Clinical Trials and Patient Recruitment for Rheumatoid Arthritis3614
  Rheumatoid Arthritis- Overview361
  Clinical Trials for Rheumatoid Arthritis371
    Number of Clinical Trials by Stage of Development371
    Number of Clinical Trials by Sponsor381
    Number of Clinical Trials by Geography391
    Number of Clinical Trials by Year401
  Patient Recruitment for Rheumatoid Arthritis411
    Number of Patients Recruited by Stage of Development411
    Number of Patients Recruited by Sponsor421
    Number of Patients Recruited by Geography431
    Number of Patients Recruited by Year441
  Average Number of Patients Recruited per Trial451
    Average Number of Patients Recruited per Trial by Stage of Development451
    Average Number of Patients Recruited per Trial per Year461
  Prevalence Population for Rheumatoid Arthritis in Brazil, China and India471
    Prevalence Population for Rheumatoid Arthritis in Brazil (2010-2017)471
    Prevalence Population for Rheumatoid Arthritis in China (2010-2017)481
    Prevalence Population for Rheumatoid Arthritis India (2010-2017)491
Clinical Trials and Patient Recruitment for Crohn s Disease5014
  Crohn s Disease- Overview501
  Clinical Trials for Crohn s Disease511
    Number of Clinical Trials by Stage of Development511
    Number of Clinical Trials by Sponsor521
    Number of Clinical Trials by Geography531
    Number of Clinical Trials by Year541
  Patient Recruitment for Crohn s Disease551
    Number of Patients Recruited by Stage of Development551
    Number of Patients Recruited by Sponsor561
    Number of Patients Recruited by Geography571
    Number of Patients Recruited by Year581
  Average Number of Patients Recruited per Trial591
    Average Number of Patients Recruited per Trial by Stage of Development591
    Average Number of Patients Recruited per Trial per Year601
  Prevalence Population for Crohn s Disease in Brazil, China and India611
    Prevalence Population for Crohn s Disease in Brazil (2010-2017)611
    Prevalence Population for Crohn s Disease in China (2010-2017)621
    Prevalence Population for Crohn s Disease India (2010-2017)631
Clinical Trials and Patient Recruitment for Ulcerative Colitis6414
  Ulcerative Colitis- Overview641
  Clinical Trials for Ulcerative Colitis651
    Number of Clinical Trials by Stage of Development651
    Number of Clinical Trials by Sponsor661
    Number of Clinical Trials by Geography671
    Number of Clinical Trials by Year681
  Patient Recruitment for Ulcerative Colitis691
    Number of Patients Recruited by Stage of Development691
    Number of Patients Recruited by Sponsor701
    Number of Patients Recruited by Geography711
    Number of Patients Recruited by Year721
  Average Number of Patients Recruited per Trial731
    Average Number of Patients Recruited per Trial by Stage of Development731
    Average Number of Patients Recruited per Trial per Year741
  Prevalence Population for Ulcerative Colitis in Brazil, China and India751
    Prevalence Population for Ulcerative Colitis in Brazil (2010-2017)751
    Prevalence Population for Ulcerative Colitis in China (2010-2017)761
    Prevalence Population for Ulcerative Colitis India (2010-2017)771
Clinical Trials and Patient Recruitment for Psoriasis7814
  Psoriasis- Overview781
  Clinical Trials for Psoriasis791
    Number of Clinical Trials by Stage of Development791
    Number of Clinical Trials by Sponsor801
    Number of Clinical Trials by Geography811
    Number of Clinical Trials by Year821
  Patient Recruitment for Psoriasis831
    Number of Patients Recruited by Stage of Development831
    Number of Patients Recruited by Sponsor841
    Number of Patients Recruited by Geography851
    Number of Patients Recruited by Year861
  Average Number of Patients Recruited per Trial871
    Average Number of Patients Recruited per Trial by Stage of Development871
    Average Number of Patients Recruited per Trial per Year881
  Prevalence Population for Psoriasis in Brazil, China and India891
    Prevalence Population for Psoriasis in Brazil (2010-2017)891
    Prevalence Population for Psoriasis in China (2010-2017)901
    Prevalence Population for Psoriasis India (2010-2017)911
Appendix924
  Market Definitions921
  Abbreviations921
  Research Methodology923
    Clinical Trials Overview931
    Number of Clinical Trials931
    Patient Recruitment Status931
    Prevalence of Disease in India, China and Brazil (2010-2017)931
    Primary Research941
    Expert Panel Validation941
  Contact Us941
  Disclaimer941
  Sources951

Table Of Contents

GBI Research Reports—GBI Research covers worldwide markets and issues, supplies actionable data and forecasts and is driven by industry leaders' insights. GBI Research provides a broad spectrum of reports across the healthcare and energy industries and its online offering is easy to navigate - a comprehensive resource for business information needs.

About the Author


Cite this Report

  
MLA:
GBI Research Reports. "Clinical Trial Recruitment in Autoimmune Disorders-Average Patient Recruitment Per Trial has Continued to Decline Over the Past Decade" Sep 01, 2011. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GBI-Research-Reports/Clinical-Trial-Recruitment-in-Autoimmune-Disorders-Average-Patient-Recruitment-Per-Trial-has-Continued-to-Decline-Over-the-Past-Decade-2115-248>
  
APA:
GBI Research Reports. (2011). Clinical Trial Recruitment in Autoimmune Disorders-Average Patient Recruitment Per Trial has Continued to Decline Over the Past Decade Sep 01, 2011. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GBI-Research-Reports/Clinical-Trial-Recruitment-in-Autoimmune-Disorders-Average-Patient-Recruitment-Per-Trial-has-Continued-to-Decline-Over-the-Past-Decade-2115-248>
  
US$ 3,500.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.